Drug intelligence / Profile preview

SST-0225

Development stage
Phase 2
Lead developer
Strategic Science & Technologies
Modality
Hydrogel Systems → Drug Delivery Systems, Small Molecules, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
Administration
Topical
01

Overview

SST-0225 is a patented topical cream formulation of ibuprofen developed for the treatment of acute pain, including delayed onset muscle soreness (DOMS), myalgia, and ankle injuries. It utilizes Strategic Science & Technologies' proprietary KNOSIS delivery technology to enhance local tissue penetration of ibuprofen while minimizing systemic absorption. This targeted delivery aims to provide rapid pain relief with reduced risk of systemic side effects compared to oral NSAIDs. Clinical trials have demonstrated that SST-0225 is safe and well-tolerated, offering potential advantages such as faster onset of action and improved safety profile over traditional oral formulations[1][4][6][8].

Other names
SST-0225 topical ibuprofen creamSST0225 topical ibuprofen creamSST 0225 topical ibuprofen cream
02

Targets

PGHS-1 (Prostaglandin G/H Synthase 1)

Beyond the preview

Go deeper on SST-0225.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on SST-0225.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call